| P50 | author | Jean-Pierre J Issa | Q55459879 |
| | Hagop Kantarjian | Q60394812 |
| | Carlos B Bueso-Ramos | Q90223571 |
| | Woonbok Chung | Q92086738 |
| | Kimie Kondo | Q117223256 |
| P2093 | author name string | Li Zhang | |
| | Lanlan Shen | |
| | Jaroslav Jelinek | |
| | Rong He | |
| | Marcos R H Estécio | |
| | Heike Kroeger | |
| P2860 | cites work | High sensitivity mapping of methylated cytosines | Q24630600 |
| | Sensitive and quantitative universal Pyrosequencing methylation analysis of CpG sites | Q28187720 |
| | Cadherin-13, a mediator of calcium-dependent cell-cell adhesion, is silenced by methylation in chronic myeloid leukemia and correlates with pretreatment risk profile and cytogenetic response to interferon alfa | Q28191349 |
| | Inactivation of p57KIP2 by regional promoter hypermethylation and histone deacetylation in human tumors | Q28215348 |
| | The epigenomics of cancer | Q28289975 |
| | Transcriptional silencing of the p73 gene in acute lymphoblastic leukemia and Burkitt's lymphoma is associated with 5' CpG island methylation. | Q30322368 |
| | Aberrant DNA methylation of p57KIP2 identifies a cell-cycle regulatory pathway with prognostic impact in adult acute lymphocytic leukemia | Q33186068 |
| | Genome-wide profiling of DNA methylation reveals a class of normally methylated CpG island promoters | Q33304220 |
| | Hypermethylation and silencing of the putative tumor suppressor Tazarotene-induced gene 1 in human cancers | Q34310451 |
| | Global assessment of promoter methylation in a mouse model of cancer identifies ID4 as a putative tumor-suppressor gene in human leukemia | Q34396332 |
| | Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis | Q34455183 |
| | Silencing of bidirectional promoters by DNA methylation in tumorigenesis | Q34527442 |
| | Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia | Q34553286 |
| | High-throughput methylation profiling by MCA coupled to CpG island microarray | Q36004673 |
| | Genetics of myeloid malignancies: pathogenetic and clinical implications | Q36254578 |
| | Epigenetic changes in solid and hematopoietic tumors. | Q36279348 |
| | Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia | Q36612343 |
| | Oligonucleotide inhibitors of Taq DNA polymerase facilitate detection of low copy number targets by PCR. | Q36836246 |
| | The C/EBPdelta tumor suppressor is silenced by hypermethylation in acute myeloid leukemia | Q38305661 |
| | Methylation silencing of the Apaf-1 gene in acute leukemia | Q40406002 |
| | Aberrant DNA methylation associated with silencing BNIP3 gene expression in haematopoietic tumours. | Q40448817 |
| | Phase II study of low-dose decitabine in patients with chronic myelogenous leukemia resistant to imatinib mesylate | Q40508930 |
| | A simple method for estimating global DNA methylation using bisulfite PCR of repetitive DNA elements | Q40587967 |
| | Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification | Q40951949 |
| | The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. | Q41223399 |
| | Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. | Q41228119 |
| | JAK2 mutation 1849G>T is rare in acute leukemias but can be found in CMML, Philadelphia chromosome-negative CML, and megakaryocytic leukemia | Q42182981 |
| | Demethylation of a hypermethylated P15/INK4B gene in patients with myelodysplastic syndrome by 5-Aza-2'-deoxycytidine (decitabine) treatment | Q44155422 |
| | Progesterone receptor gene inactivation and CpG island hypermethylation in human leukemia cancer cells. | Q44922040 |
| | Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemia | Q46758045 |
| | Methylation profiling in acute myeloid leukemia. | Q53729917 |
| | Promoter hypermethylation of the retinoic acid receptor beta2 gene is frequent in acute myeloid leukaemia and associated with the presence of CBFbeta-MYH11 fusion transcripts. | Q54605238 |
| | RIL, a LIM gene on 5q31, is silenced by methylation in cancer and sensitizes cancer cells to apoptosis. | Q55043439 |
| | Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene | Q57208389 |
| | Methylation and prognosis: of molecular clocks and hypermethylator phenotypes | Q73796635 |
| | CpG island methylator phenotype redefines the prognostic effect of t(12;21) in childhood acute lymphoblastic leukemia | Q80129003 |
| | CpG island methylator phenotype in cancer | Q81080870 |
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | leukemia | Q29496 |
| | CpG island | Q1138360 |
| | acute myeloid leukemia | Q264118 |
| P304 | page(s) | 1366-1373 | |
| P577 | publication date | 2008-06-03 | |
| P1433 | published in | Blood | Q885070 |
| P1476 | title | Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse | |
| P478 | volume | 112 | |